Nova Eye Medical Launches Multi-Center ‘CATALYST’ Study in Europe to Investigate Canaloplasty with the new iTrack™ Advance
Media Release iTrack
11 Aug, 2022
Nova Eye Medical Announces Global Data Registry to Support Role of Canaloplasty for Glaucoma
Media Release iTrack
4 Aug, 2022
Peer Review Publication of 36- and 48-month Canaloplasty Data Demonstrates Sustained Reduction in IOP with iTrack™
Media Release iTrack
5 May, 2022
Nova Eye Medical Launches Next Generation Canaloplasty Device for Glaucoma, iTrack™ Advance
Media Release General iTrack
19 Apr, 2022
iTrack™ Canaloplasty to be Featured at the 2022 ASCRS Annual Meeting
Media Release General iTrack
12 Apr, 2022
Nova Eye, Inc., President Appointed to American Glaucoma Society (AGS) Foundation Advisory Board
Media Release General iTrack
31 Mar, 2022
iTrack™ to be Featured at the 2022 American Glaucoma Society (AGS) Annual Meeting
Media Release iTrack
8 Mar, 2022
One Year Evaluation of Endothelial Cell Density Following iTrack™ to be Spotlighted at ESCRS 2021
Media Release General iTrack
8 Oct, 2021
5-Year Effectiveness and Safety Data for iTrack™ to be Spotlighted at ESCRS 2021
Media Release General iTrack
8 Oct, 2021
For media enquires please contact:
Kate Hunt
Nova Eye Medical Limited
W +61 404 080 679
khunt@nova-eye.com
This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More
The cookies do not store any personalised information. Learn More